a decreasing trendP < 0.05
Cell counts of CD45 + , CD3 + T, CD3 + CD4 + Th, CD3 + CD8 + CTL, CD16 + CD56 + NK and CD19 + B demonstrated a decreasing trend as the disease entered its advanced stage ( P < 0.05, Fig. 3 G-L).
Cell counts of CD45 + , CD3 + T, CD3 + CD4 + Th, CD3 + CD8 + CTL, CD16 + CD56 + NK and CD19 + B demonstrated a decreasing trend as the disease entered its advanced stage ( P < 0.05, Fig. 3 G-L).
However, an increasing trend of PD-1 positive cells was presented with age and tumor stage in whole cancer patients.